FROM THE EDITOR-IN-CHIEF
T cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
Targeted Chemotherapy | Drug Combo Targets Polyp Growth | FDA Acts to Curb Nicotine Use | Cloning Cancer | Putting Age in the Cancer Picture | Back to School | What’s Next?
The number of cancer survivors is growing. We must step up efforts to meet their needs.
by Elizabeth M. Jaffee, MD
YOUR CANCER GUIDE
A second opinion can provide additional information to determine the best treatment course.
by Hester Hill Schnipper
CAREGIVING WITH CONFIDENCE
Recognize the signs of a serious mental illness and get help if you need it.
by Lisa O’Leary
Janet Freeman-Daily helps put patients at the center of lung cancer research.
by Robin Meadows
People with metastatic breast cancer are demanding to be seen, counted and included in breast cancer research.
by Sue Rochman
Cancer rehabilitation can help patients before and after treatment, but it’s still not widely used.
by Cameron Walker
After decades without treatment advances, options for patients with bladder cancer are now more numerous.
by Kendall K. Morgan
Go Fish | Against the Clock
Palliative care specialist Jessica Nutik Zitter offers tips to help ensure that patients’ values guide end-of-life decisions.
by Marci A. Landsmann
A patient support expert offers guidance on how to respond to news of a friend’s cancer diagnosis.
Help with Hope delivers care packages to young people whose mother or father has received a cancer diagnosis.
by Lindsey Konkel
Tanya Waring-Hearn, Amy Rowley, Elsie Young.
My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.
by Allison Rosen
Researchers are investigating why certain patients have an exceptional response to a particular drug.
by Bradley Jones
Some cancers that are most commonly diagnosed in older adults are becoming increasingly prevalent in young adults.
by Kate Yandell
An analysis of cancer patients who were infected with the coronavirus and treated at Memorial Sloan Kettering Cancer Center in New York City suggests certain risk factors may predict more severe COVID-19.
by Anna Azvolinsky
Researchers discussed the impact of COVID-19 on minority populations and recent research in the COVID-19 field.
The FDA has expanded the use of the PARP-targeted therapeutic olaparib to include the treatment of certain patients with metastatic prostate cancer.
While melanoma is rarer than other forms of skin cancer, it is more aggressive and more likely to spread to other organs.
Handle With Care
donate to the AACR